Aspargo Laboratories, Inc. is a life sciences company formed for the purpose of commercializing an innovative formulation of sildenafil citrate, the active ingredient in VIAGRA®, to address the large clinical need for drugs that treat erectile dysfunction, one of the most common sexual dysfunction problems that men report to their doctors.


Our executive leadership team is comprised of veterans in the specialty pharma and biotech industries, with decades of experience in developing and marketing disruptive therapeutic agents, preparing and submitting FDA and EMA regulatory submissions and obtaining drug approvals in the United States and abroad. Members of our Medical Advisory Board have authored reports in dozens of peer-reviewed publications, including in the field of sexual medicine. Our leadership team is experienced in investor relations and public relations, adept at managing healthcare capital markets and structuring and executing going public and other strategic transactions.